Clinical and immunological spectrum of the Miller Fisher syndrome

Muscle and Nerve

Volumn 36, Issue 5, 2007, Pages 615-627

  Lo, Y L ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Anti GQ1b IgG antibody; Bickerstaff's brainstem encephalitis; Guillain Barr ; Miller Fisher syndrome; Review; Syndrome

Indexed keywords

AP 7070; GANGLIOSIDE GQ 1B ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOMODULATING AGENT; MICROCOCEPT; UNCLASSIFIED DRUG;

ANTIBODY TITER; AREFLEXIA; ATAXIA; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BICKERSTAFF BRAINSTEM ENCEPHALITIS; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; ENCEPHALITIS; GUILLAIN BARRE SYNDROME; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; MOLECULAR MIMICRY; NEOPLASM; NEUROMUSCULAR TRANSMISSION; NEURORADIOLOGY; NONHUMAN; OPHTHALMOPLEGIA; PRIORITY JOURNAL; REVIEW;

ANTIBODIES; GANGLIOSIDES; HUMANS; MILLER FISHER SYNDROME;

EID: 35449006354     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20835     Document Type: Review

References (181)

1. Alaedini A, Briani C, Wirguin I, Siciliano G, D'Avino C, Latov N. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay. J Neurol Sci 2002;196:41-44.
2. Al-Din SN, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuroophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand 1994;89:157-163.
3. Ang CW, De Klerk MA, Endtz HP, Jacobs BC, Laman JD, van der Meche FG, et al. Guillain-Barré syndrome and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits. Infect Immun 2001;69:2462-2469.
4. Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, et al. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect Immun 2002;70:1202-1208.
5. Arai M, Odaka M, Yuki N, Hirata K. A patient with overlapping Bickerstaffs brainstem encephalitis, Miller Fisher syndrome and Guillain-Barré syndrome during the clinical course. Eur J Neurol 2002;9:115-116.
6. Arakawa Y, Yoshimura M, Kobayashi S, Ichihashi K, Miyao M, Momoi MY, et al. The use of intravenous immunoglobulin in Miller Fisher syndrome. Brain Dev 1993;15:231-233.
7. Arranz Caso JA, Martinez R, Cabrera F, Tejeiro J. Miller Fisher syndrome in a patient with HIV infection. AIDS 1997; 15:550-551.
8. Aspinall GO, Fujimoto S, McDonald AG, Pang H, Kurjanczyk LA, Penner JL. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun 1994;62:2122-2125.
9. Barontini F, Di Lollo S, Maurri S, Lambruschini P. Localization of the pathological process in Miller Fisher syndrome. Ital J Neurol Sci 1992;13:221-225.
10. Benito-Leon J, Bravo J, Mateos F, Simon R. Miller Fisher syndrome in infancy. Child Nerv Syst 1996;12:559-561.
11. Bennetto LP, Lyons P. Miller Fisher syndrome associated with Pastuerella multocida infection. J Neurol Neurosurg Psychiatry 2004;75:1786-1787.
12. Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroopthalmol 1992;12:57-63.
13. Bingisser R, Speich R, Fontana A, Gmur J, Vogel B, Landis T. Lupus erythematosus and Miller Fisher syndrome. Arch Neurol 1994;51:828-830.
14. Blau I, Casson I, Lieberman A, Weiss E. The not-so-benign Miller Fisher syndrome: a variant of Guillain-Barré syndrome. Arch Neurol 1980;37:384-385.
15. Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculopathy in Lombardi, Italy, 1996. Acta Neurol Scand 2004;110:100-106.
16. Brittain CJ, Lake D. Acute angle closure in Miller Fisher syndrome. Eye 2006;20:739-740.
17. Buchwald B, Bufler J, Carpa M, Heidenreich F, Pitz R, Dudel J, et al. Combined pre- and post-synaptic action of IgG antibodies in Miller Fisher syndrome. Neurology 2001;56: 67-74.
18. Buchwald B, Weishaupt A, Toyka KV, Dudel J. Immunoglobulin G from a patient with Miller Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett 1995;201:163-166.
19. Buchwald B, Weishaupt A, Toyka KV, Dudel J. Pre- and postsynaptic blockade of neuromuscular transmission by Miller Fisher syndrome IgG at mouse motor nerve terminals. Eur J Neurosci 1998;10:281-290.
20. Bullens RW, O'Hanlon GM, Goodyear CS, Molenaar PC, Conner J, Willison HJ, et al. Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates. Muscle Nerve 2000;23:1035-1043.
21. Caccavale A, Mignemi L. Acute onset of a bilateral areflexical mydriasis in Miller Fisher syndrome: a rare neuro-ophthalmologic disease. J Neuroophthalmol 2000;20:61-62.
22. Carpo M, Pedotti R, Allaria S, Lolli F, Mata S, Cabaletti G, et al. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 1999;168:78-84.
23. Chan JW. Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome. Br J Ophthalmol 2003;87:1185-1186.
24. Chan YC, Wilder-Smith E, Chee MW. Acute ophthalmoplegia with pupillary areflexia associated with anti-GQ1b antibody. J Clin Neurosci 2004;11:658-660.
25. Cheng BC, Chang WN, Chang CS, Chee CY, Huang CR, Chen JB, et al. Guillain-Barré syndrome in southern Taiwan: clinical features, prognostic factors and therapeutic outcomes. Eur J Neurol 2003;10:655-662.
26. Chiba A, Kusunoki S, Kuwata S, Juji T, Shibata Y, Kanazawa I. HLA and anti-GQ1b antibody in Miller Fisher syndrome and Guillain-Barré syndrome. J Neuroimmunol 1995;61:85-88.
27. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special references to pathophysiology' of Miller Fisher syndrome. Brain Res 1997;754:32-36.
28. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
29. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-679.
30. Chiba A, Sugiyama T, Yonekura K, Tanaka S, Matsumoto H, Fujii N, et al. An antibody to VacA of Helicobacter pylori in the CSF of patients with Miller Fisher syndrome. Neurology 2004;63:2184-2186.
31. Chiba S, Sugiyama T, Yonekura K, Tanaka S, Matsumoto H, Fujii N, et al. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid of patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2002;73:76-78.
32. Chikakiya H, Kunishige M, Yoshino H, Asano A, Sumitomo Y, Endo I, et al. Delayed motor and sensory neuropathy in a patient with brainstem encephalitis. J Neurol Sci 2005;234: 105-108.
33. Colding-Jorgensen E, Vissing J. Visual impairment in anti-GQ1b positive Miller Fisher syndrome. Acta Neurol Scand 2001;103:259-260.
34. Collier J. Peripheral neuritis. Edinburgh Med J 1932;39:601-618.
35. Csepany T, Boczan J, Magyar MT, Molnar S, Csiba L, Deesy J, et al. Miller Fisher syndrome - a presenting clinical manifestation of lung cancer in a previously apparently healthy individual. J Neurol 2004;251:898-900.
36. Derakhshan 1. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology 2000;55:1419-1420.
37. Desai SS, Allen E, Deodhar A. Miller Fisher syndrome in adult onset Still's disease: case report and review of the literature of other neurological manifestations. Rheumatology (Oxford) 2002;41:216-222.
38. Diaz Ortuna A, Maeztu C, Munoz JA, Reigadas R, Reigadas R, Rodriguez T, et al. Miller Fisher syndrome associated with Q fever. J Neurol Neurosurg Psychiatry 1990;53:61561-61516.
39. Finsterer J, Niedermayr A, Weigl PG, Voigtlander T. Anti-GQ1b-negative Miller Fisher syndrome with lower cranial nerve involvement from parasinusoidal Aspergilloma. J Infect 2006; 2: 81-85.
40. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
41. Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493-1498.
42. Giroud M, Mousson C, Chalopin JM, Rifle G, Dumas R. Miller Fisher syndrome and pontine abnormalities on MRI: a case report. J Neurol 1990;237:489-490.
43. Godschalk PC, Bergman MP, Gorkink RF, Simons G, van dern Braak N, Lastovica AJ, et al. Identification of DNA sequence variation in Campylobacter strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis. BMC Microbiol 2006;6:32.
44. Godschalk PG, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, et al. The crucial role of Campylobacter jejuni anti-ganglioside antibody induction in Guillain-Barré syndrome. J Clin Invest 2004;114:1659-1665.
45. Goffete S, Jeanjean A, Pierret F, Peeters A, Sindic CJ. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndrome. Acta Neurol Belg 1998;98:322-326.
46. Goldberg-Stern H, Melamed E, Gadoth N. Abnormal evoked potentials in Miller Fisher syndrome: further evidence of combined peripheral and central demyelination. J Neurol Neurosurg Psychiatry 1994;57:506.
47. Guiloff RJ. Peripheral nerve conduction in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1977;40:801-807.
48. Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, Willison HJ. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol 2005;58:203-210.
49. Halstead SK, Morrison I, O'Hanlon GM, Humphreys PD, Goodfellow JA, Plomp JJ, et al. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia 2005;53:177-189.
50. Halstead SK, O'Hanlon GM, Humphreys PD, Morrison DB, Morgan DP, Todd AJ, et al. Anti-disialoside antibodies kill presynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 2004;127:2109-2123.
51. Hamaguchi T, Yamaguchi K, Komai K, Yamada M, Yokoji H, Satake R, et al. Recurrent anti-GQ1b IgG antibody syndrome showing different phenotypes in different periods. J Neurol Neurosurg Psychiatry 2003;74:1350.
52. Harukawa H, Utsumi H, Asano A, Yoshino H. Anti-LM1 antibodies in the sera of patients with Guillain-Barré syndrome, Miller Fisher syndrome, and motor neuron disease. J Peripher Nerv Syst 2002;7:54-58.
53. Hatanaka T, Higashino H, Yasuhara A, Kobayashi Y. Miller Fisher syndrome: etiological significance of serial blink reflexes and MRI study. Electromyogr Clin Neurophysiol 1992; 32:317-319.
54. Hess DC, Awad E, Posas H, Sethi KD, Adams RJ. Miller Fisher syndrome in systemic lupus erythematosus. J Rheumatol 1990;17:1520-1522.
55. Hirakawa M, Morita D, Tsuji S, Kusunoki S. Effects of phospholipids on antigangioside antibody reactivity. J Neuroimmunol 2005;159:129-132.
56. Hohnoki K, Inoue A, Koh CS. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. J Neuroimmunol 1998;87:27-32.
57. Hosoya T, Adachi M, Yamaguchi K, Kato T, Sugai Y. Abducens nerve enhancement demonstrated by multiplanar reconstruction of contrast-enhanced three-dimensional MRI. Neuroradiology 201;43:295-301.
58. Hung PL, Chang WN, Huang LT, Huang SC, Chang YC, Chang CJ, et al. A clinical and electrophysiologic survey of childhood Guillain-Barré syndrome. Pediatr Neurol 2004; 30:86-91.
59. Ilyas AA, Cook SD, Mitchen FA, Taki T, Kasama T, Handa S, et al. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome. J Neuroimmunol 1998;82:160-167.
60. Inoue A, Koh G, Iwahashi T. Detection of serum anticerebellar antibodies in patients with Miller Fisher syndrome. Eur Neurol 1999;42:230-234.
61. Inoue N, Ichimura H, Goto S, Hashimoto Y, Ushio Y. MR imaging findings of spinal posterior column involvement in a case of Miller Fisher syndrome. Am J Neuroradiol 2004; 25:645-648.
62. Jacobs BC, Endtz H, van der Meche FG, Hazenberg MP, Achtereekte HA, van Doorn HA. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 1995;37:260-364.
63. Jacobs BG, Endtz HP, van der Mcche FG, Hazenberg MP, de Klerk MA, van Doorn PA. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome. J Neuroimmunol 1997; 79:62-68.
64. Jacobs BG, O'Hanlon GM, Breedland EG, Veitch J, van Doorn PA, Willison HJ. Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides. J Neuroimmunol 1997;80:23-30.
65. Jacobs BC, O'Hanlon GM, Bullens RW, Veitch J, Plomp J, Willison HJ. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 2003;126: 2220-2234.
66. Jamal GA, Ballantyne JP. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). A serial multimodal neurophysiological study. Brain 1988;111:95-114.
67. Jamal GA, MacLeod WN. Electrophysiologic studies in Miller Fisher syndrome. Neurology 1984;34:685-688.
68. Kaida KL, Kanzaki M, Morita D, Kamakura K, Motoyoshi K, Hirakawa M, et al. Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2006; 77:1043-1046.
69. Kaplan JG, Schaumburg HH, Sumner A. Relapsing ophthalmoparesis-sensory neuropathy syndrome. Neurology 1985; 35:595-596.
70. Katsuno M, Ando T, Hakusui S, Yanagi T, Sobue G. Motor conduction studies in Miller Fisher syndrome with severe tetraparesis. Muscle Nerve 2002;25:378-382.
71. Kaushik P, Cohen AJ, Zuckerman SJ, Vatsavai SR, Pepper SJ, Banda VR, et al. Miller Fisher variant of Guillain-Barré syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation. Ann Pharmacother 2005;39:1124-1127.
72. Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furakawa K, et al. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 2005;64:1605-1611.
73. Koga M, Koike S, Hirata K, Yuki N. Ambiguous value of Hemophilus influenzae isolation in Guillain-Barré and Fisher syndromes. J Neurol Neurosurg Psychiatry 2005;76:1736-1738.
74. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology 2005;65:1376-1381.
75. Koga M, Yuki N, Tai T, Hirata K. Miller Fisher syndrome and Hemophilus influenzae infection. Neurology 2001;57:686-691.
76. Koga M, Yuki N, Takahashi M, Saito K, Hirata K. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndrome. J Neuroimmunol 1998;81:138-143.
77. Koga M, Yuki N, Tsukada Y, Hirata K, Matsumoto Y. CDR3 spectratyping analysis of the T cell receptor repetoire in Guillain-Barré and Fisher syndromes. J Neuroimmunol 2003;141:112-117.
78. Koga M, Yuki N, Hirata K. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis. J Neuroimmunol 1999;96:245-250.
79. Koga M, Yuki N, Hirata K. Pain in Miller Fisher syndrome. J Neurol 2000;247;720-721.
80. Kornberg AJ, Pestronk A, Blume GM, Lopate G, Yue J, Hahn A. Selective staining of the cerebellar molecular layer by serum IgG of Miller Fisher and related syndromes. Neurology 1996;47:1317-1320.
81. Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 1999;22:1071-1074.
82. Kuwabara S, Asahina M, Nakajima M, Mori M, Fukutake T, Hattori T, et al. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol 1999;45:533-536.
83. Lange DJ, Deangelis T, Sivak MA. Single-fiber electromyography shows terminal axon dysfunction in Miller Fisher syndrome: a case report. Muscle Nerve 2006;34:232-234.
84. Li HF, Xie YC. Posterior column involvement in Miller Fisher syndrome or dorsal root ganglion neuronopathy? Am J Neuroradiol 2005;26:1881.
85. Littelwood R, Bajada S. Successful plasmapharesis in the Miller Fisher syndrome. Br Med J (Clin Res Ed) 1981;282: 778.
86. Lo YL, Chan LL, Pan A, Ratnagopal P. Acute ophthalmoparesis with anti-GQ1b antibody: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi. J Neurol Neurosurg Psychiatry 2003;75:436-440.
87. Lo YL, Dan YF, Leoh TH, Tan YE, Nurjannah S, Ratnagopal P. The effect of exercise on repetitive nerve stimulation studies: new appraisal of an old technique. J Clin Neurophysiol 2004;21:110-113.
88. Lo YL, Dan YF, Leoh TH, Tan YE, Ratnagopal P. Decrement in area of muscle responses to repetitive nerve stimulation. Muscle Nerve 2003;27:494-496.
89. Lo YL, Leoh TH, Dan YF, Tan YE, Nurjannah S, Ratnagopal P. Repetitive stimulation of the long thoracic nerve. J Neurol Neurosurg Psychiatry 2003;74:379-381.
90. Lo YL, Leoh TH, Dan YF, Lim LL, Seah A, Fook-Chong S, et al. Presynaptic neuromuscular transmission defect in the Miller Fisher syndrome. Neurology 2006;66:148-149.
91. Lo YL, P Ratnagopal. Transcranial magnetic stimulation studies in the Miller Fisher syndrome: evidence of corticospinal tract abnormality'. J Neurol Neurosurg Psychiatry 2001;71:210-214.
92. Lo YL, Ratnagopal P. Corticobulbar dysfunction in the Miller Fisher syndrome. Clin Neurol Neurosurg 2003;105: 156-158.
93. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997;63:494-500.
94. Lyu RK, Tang LM, Hsu WC, Chen ST. Quantitative cardiovascular autonomic function study in Fisher syndrome. J Neurol Neurosurg Psychiatry 2002;73:333-335.
95. Madhavan S, Geetha N, Bhargavan PV. Recurrent Miller Fisher syndrome. J Assoc Physicians India 2004;52:582-584.
96. Maisey DN, Olczak SA. Successful plasmapharesis in the Miller Fisher syndrome. Br Med J (Clin Res Ed) 1981;282: 1159.
97. Matsumoto H, Kobayashi O, Tamura K, Ohkawa T, Sekine I. Miller Fisher syndrome with transient coma: comparison with Bickerstaff's brainstem encephalitis. Brain Dev 2002;24: 98-101.
98. McCombe PA, Wilson R, Prentice RL. Results of testing for anti-GM1 antibodies. J Clin Neurosci 2000;7:209-212.
99. Merkx H, Keyser J, Ebinger G. Miller Fisher syndrome associated with Mycoplasma pneumoniae infection: report of a case. Clin Neurol Neurosurg 1994;96:96-99.
100. Minguez M, Reus S, Pascual E. Dorsal-lumbar pain as the first manifestation of Miller Fisher syndrome. Clin Exp Rheumatol 1998;16:509.
101. Minoda R, Uno K, Toriya T, Eura M, Noguchi S, Masuyama K. Neurologic and otologic findings in Fisher's syndrome. Auris Nasus Larynx 1999;26:153-158.
102. Miyazaki T, Kusunoki S, Kaida K, Shiina M, Kanazawa I. Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b. Neurology 2001;56:1227-1229.
103. Mizoguchi K. Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome. Neurol Res 1998;20: 617-624.
104. Mori M, Kuwabara S, Fukutake T, Hattori T. Plasmapharesis and Miller Fisher syndrome: analysis of 50 consecutive cases. J Neurol Neurosurg Psychiatry 2002;72:680.
105. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104-1106.
106. Mori M, Kuwabara S, Koga M, Asahina M, Ogawara K, Hattori T, et al. IgG anti-GQ1b antibody positive acute ataxia without ophthalmoplegia. J Netrrol Neurosurg Psychiatry 1999;69:668-670.
107. Nagaoku U, Kato T, Kurita K, Arawaka S, Hosoya T, Yuki N, et al. Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology 1996;47:1601-1602.
108. Nakajima M. Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with Miller Fisher syndrome. J Neurol 2005;54:58-60.
109. Nakatsuji Y, Sadahiro S, Watanabe S, Fujimura H, Abe K, Koguchi K, et al. Leptomeningeal signet-ring cell carcinomatosis presenting with ophthalmoplegia, areflexia and ataxia. Clin Neuropathol 2001;20:272-275.
110. Neisser A, Bernheimer H, Berger T, Moran AP, Schwerer B. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect Immun 1997;65:4038-4042.
111. Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol 2004;148:200-205.
112. Nishino S, Kanbayashi T, Fujiki N, Uchino M, Ripley B, Watanabe M, et al. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology 2003;61:823-825.
113. O'Leary CP, Vetich J, Durward WF, Thomas AM, Rees JH, Willison HJ. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996;61:649-651.
114. O'Hanlon GM, Humphreys PD, Goldman RS, Halstead SK, Bullens RW, et al. Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain 2003;126:2497-2509.
115. O'Hanlon GM, Plomp JJ, Chakrabarti M, Morrison I, Wagner ER, Goodyear CS, et al. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 2001;124:893-906.
116. Odaka M, Koga M, Yuki N, Susuki K, Hirata K. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis. J Neurol Sci 2003;21:99-103.
117. Odaka M, Yuki N, Hirata K. Anti-GQ1b antibody syndrome: clinical and immunological range. J Netrrol Neurosurg Psychiatry 2001;70:50-55.
118. Odaka M, Yuki N, Hirata K. Bilateral ballism in a patient with overlapping Fisher's and Guillain-Barré syndromes. J Neurol Neurosurg Psychiatry 1999;67:206-208.
119. Odaka M, Yuki N, Tatsumoto M, Tateno M, Hirata K. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNac-GD1a antibodies. J Neurol 2004;251:24-29.
120. Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003;126:2279-2290.
121. Ogawara K, Kuwabara S, Yuki N. Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems. Muscle Nerve 2002;26:845-849.
122. Ohtsuka K, Nakamura Y, Hashimoto M, Tagawa Y, Takahashi M, Saito K, et al. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ophthalmology 1998;105;1281-1285.
123. Ohtsuka K, Nakamura Y, Tagawa Y, Yuki N. Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody. Am J Ophthalmol 1998;125:403-406.
124. Oomura M, Yamawaki T, Oe H, Moriwaki H, Miyashita K, Naritomi H, et al. Association of cardiomyopathy caused by autonomic nervous system impairment with the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2003;74: 689-690.
125. Orr CF, Storey CE. Recurrent Miller Fisher syndrome. J Clin Neurosci 2004;11:307-309.
126. Panda S, Tripathi M. Anti-GQ1b antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2002;72:418-419.
127. Paparounas K. Anti-GQ1b ganglioside antibody in peripheral nervous system disorders: pathophysiologic role and clinical relevance. Arch Neurol 2004;61:1013-1016.
128. Pedotti R, Carpo M, Lucchi S, Righini A, Scarlato G, Nobile-Orazio E. Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome. J Neurol 1998;245:753-754.
129. Phillips MS, Stewart S, Anderson JR. Neuropathological findings in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1984;47:492-495.
130. Pinchoff BS, Slavin MI, Rosenstein D, Hyman R. Divergence paralysis as the initial sign in the Miller Fisher syndrome. Am J Ophthalmol 1986;101:741-742.
131. Plomp JJ, Molenaar PC, O'Hanlon GM, Jacobs BC, Veitch J, Daha MR, et al. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol 1999;45:189-199.
132. Polizzi A, Ruggieri M, Vecchio I, Genovese S, Rampello L, Raffacle R. Autoimmune thyroiditis and acquired demyelinating polyradiculoneuropathy. Clin Neurol Neurosurg 2001;103:151-154.
133. Pulitano S, Viola L, Genovese O, Chiaretti A, Piastra M, Mariotti P, et al. Miller Fisher syndrome mimicking intracranial hypertension following head trauma. Child's Nerv Syst 2005;21:473-476.
134. Redel SW, Barnett MH, Yan WX, Halmagyi GM, Pollard JD. Chronic ophthalmoplegia with anti-GQ1b antibody. Neurology 2000;54:1000-1002.
135. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379.
136. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 1994;343:454-455.
137. Ropper A. Absence of CNS lesion in autopsied patients with Miller Fisher syndrome. Arch Neurol 1985;42:15.
138. Ropper AH, Shahani B. Proposed mechanism of ataxia in Fisher's syndrome. Arch Neurol 1983;40:537-538.
139. Rubio-Nazabal E, Marey-Lopez J, Torres-Carrete JP, Alvarez-Perez P, Rev Del Corral P. Miller Fisher syndrome and Hodgkin's disease. J Neurol Neurosurg Psychiatry 2002;73: 344.
140. Salloway S, Mermel LA, Seamans M, Aspinall GO, Nam Shin JE, Kurjanczyk LA, et al. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human GD3. Infect Immun 1996;64:2945-2949.
141. Sartucci F, Cafforio G, Borghetti D, Domenici L, Orlandi G, Murri L. Electrophysiological evidence by single fiber electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome. Neurol Sci 2005;26:125-128.
142. Sauron B, Bouche P, Cathala HP, Chain F, Castaigne P. Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology 1984;34: 953-956.
143. Sawyer CN, Naik RB. A case of recurrent Miller Fisher syndrome. Br J Hosp Med 1987;38:566.
144. Scelsa SN, Herskovitz S. Miller Fisher syndrome: axonal, demyelinating or both? Electromyogr Clin Neurophysiol 2000;40:497-502.
145. Schapira AH, Thomas PK. A case of recurrent idiopathic ophthalmoplegic neuropathy (Miller Fisher syndrome). J Neurol Neurosurg Psychiatry 1986;49:463-464.
146. Schnorf H, Rathgeb JP, Kohler A. Anti-GQ1b positive Miller Fisher syndrome in a patient with acute Epstein-Barr virus infection and negative Campylobacter serology. Eur Neurol 1998;40:177.
147. Schwerer B, Neisser A, Bernheimer H. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection. Infect Immun 1999;67:2414-2420.
148. Schwerer B. Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome. Microbes Infect 2002;4:373-384.
149. Segurado OG, Kruger H, Mertens HG. Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders. J Neurol 1986;233:202-208.
150. Shah SS, Rodriguez T, McGowan JP. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy. Clin Infect Dis 2003;36:131-133
151. Shimamura H, Miura H, Ivvaki Y, Kubodera T, Matsuoka T, Yuki N, et al. Clinical, electrophysiological and serological overlap between Miller Fisher syndrome and acute sensory neuropathy. Acta Neurol Scand 2002;105:411-413.
152. Sitajayalakshmi S, Borgohain R, Mani J, Mohandas S. Recurrent Miller Fisher syndrome: a case report. Neurol India 2002;50:365-367.
153. Susuki K, Yuki N, Hirata K. Fine specificity of anti-GQ1b IgG and clinical features. J Neurol Sci 2001;185:5-9.
154. Suzuki T, Chiba A, Kusunoki S, Chikuda M, Fujita T, Misu K. Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause. Br J Ophthalmol 1998; 82: 916-918.
155. Takahashi M, Koga M, Yokoyama K, Yuki N, Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan. J Clin Microbiol 2005; 43:335-339.
156. Takano H, Yuki N. Fisher's syndrome associated with chickenpox and anti-GQ1b antibody. J Neurol 1995;242:255-256.
157. Tanaka H, Yuki N, Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol 1998;126:322-324.
158. Taphoorn MJ, Uitdehaag BM, Lanting P. A brainstem lesion in the Miller Fisher syndrome demonstrated by CT and MRI. J Neurol 1991;238:243.
159. Tatsumoto M, Odaka M, Hirata K, Yuki N. Isolated abducens nerve palsy as a regional variant of Guillain-Barré syndrome. J Neurol Sci 2006;243:35-38.
160. Toshniwal P. Demyelinating optic neuropathy with Miller Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination. J Neurol 1987;234:353-358.
161. Turner B, Wills AJ. Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2000;68: 790-791.
162. Urushitani M, Udaka F, Kameyama M. Miller Fisher-Guillain-Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts. J Neurol Neurosurg Psychiatry 1995; 58:241-243.
163. Van Belkum A, van den Braak N, Godschalk P, Ang W, Jacobs B, Gilbert M, et al. A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat Med 2001;7: 752-753.
164. Van der Meche FG, Van Doorn PA, Meuistee M, Jennekens FG, GBS-consensus group of the Dutch Neuromuscular Research Support Center. Diagnostic classification criteria for the Guillain-Barré syndrome. Eur Neurol 2001;45:133-139.
165. Weiss JA, White JC. Correlation of 1a afferent conduction with ataxia of Fisher syndrome. Muscle Nerve 1986;9:327-332.
166. Willison HJ, Townson K, Veitch J, Boffey J, Isaacs N, Andersen S, et al. Synthetic disialygalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain 2004;127:680-691.
167. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993;56:204-206.
168. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol 1994;50:159-165.
169. Wong V. A neurophysiological study in children with Miller Fisher syndrome and Guillain-Barré syndrome. Brain Dev 1997;19:197-204.
170. Yako K, Kusunoki S, Kanazawa I. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. J Neurol Sci 1999;168:85-89.
171. Yeh JH, Chen WH, Chen JR, Chin HC. Miller Fisher syndrome with central involvement: successful treatment with plasmapharesis. Ther Apheresis 1999;3:69-71.
172. Yuan CL, Wang YJ, Tsai CP. Miller Fisher syndrome: a hospital based retrospective study. Eur Neurol 2000;44:79-85.
173. Yuki N, Miyatake T. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection. Ann NY Acad Sci 1998;845:330-340.
174. Yuki N, Odaka N, Hitata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001;108:196-200.
175. Yuki N, Susuki K, Hirata K. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology 2000;54:1851-1853.
176. Yuki N, Taki T, Takahashi M, Saito K, Yoshino H, Tai T, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-793.
177. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter jejuni enteritis. Neurology 1990;40:1900-1902.
178. Yuki N. Infectious origins of, and molecular mimicry in Guillain-Barré and Fisher syndromes. Lancet Infect Dis 2001;1:29-37.
179. Yuki N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. J Infect Dis 1997;176(suppl):S150-S153.
180. Yuki N. Tryptophan-immobilized column absorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: a new approach to treatment. Neurology 1996;46:1644-1651.
181. Zifko U, Drlicek M, Senautka G, Griswold W. High dose immunoglobulin therapy is effective in the Miller Fisher syndrome. J Neurol 1994;241:178-179.